Search alternatives:
significant treatment » significant investment (Expand Search), significant enrichment (Expand Search), significant impairment (Expand Search)
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
treatment decrease » treatment decreased (Expand Search), treatments decreased (Expand Search), treatment increases (Expand Search)
significant treatment » significant investment (Expand Search), significant enrichment (Expand Search), significant impairment (Expand Search)
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
treatment decrease » treatment decreased (Expand Search), treatments decreased (Expand Search), treatment increases (Expand Search)
-
3141
-
3142
-
3143
ROS, K<sup>+</sup> efflux and cathepsin B are required for NLRP3 activation.
Published 2025Subjects: -
3144
-
3145
-
3146
Differences in health-related quality of life indexes after disease onset between groups.
Published 2025Subjects: -
3147
Changes in subcutaneous fat thickness and muscle mass (Approximately here).
Published 2025Subjects: -
3148
-
3149
-
3150
-
3151
-
3152
-
3153
-
3154
-
3155
-
3156
Molecular docking showed that ABT-199 can fit into active site of ALK<sup>Mutant</sup>.
Published 2025Subjects: -
3157
-
3158
-
3159
Characteristics and outcomes from clams with MarBTN and control healthy clams.
Published 2025Subjects: -
3160